The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Bad Breath On Mounjaro vs Wegovy
Bad breath (halitosis) is a reported side effect of both Mounjaro (tirzepatide) and Wegovy (semaglutide) during weight management treatment. Both are prescription-only weight loss injections that work by activating natural gut hormone pathways — but they differ in their mechanism and how frequently side effects like bad breath occur. Understanding the differences between Mounjaro and Wegovy can help you and your GP or prescriber decide which medication might be more suitable for your individual circumstances following a clinical assessment.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Bad Breath Develops On GLP-1 And GIP+GLP-1 Medications
Bad breath on weight loss injections typically occurs due to several interconnected factors. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) is a GLP-1 receptor agonist only. Both medications slow gastric emptying — the rate at which food moves through your stomach — which can lead to fermentation of food in the stomach and increased bacterial activity, creating odour-causing compounds.
- Reduced saliva flow (both medications can decrease salivation)
- Slower digestion and food fermentation in the stomach
- Dehydration, which concentrates mouth bacteria
- Nausea and digestive upset altering the oral environment
- Dietary changes during weight loss (e.g. increased protein intake)
In clinical trials, bad breath was not formally listed as a primary side effect for either medication, but patients and prescribers report it as an occasional complaint. The symptom typically improves as your body adjusts to the medication over several weeks, or resolves when the dose is optimised.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro vs Wegovy: Side Effect Profiles And Individual Variation
Clinical trial data shows both medications cause similar gastrointestinal side effects, including nausea, diarrhoea, and constipation — factors that can contribute to bad breath. SURMOUNT-1 (Mounjaro trial) and STEP-1 (Wegovy trial) did not specifically measure halitosis, so direct comparisons are limited. Individual experience varies significantly. Some people report minor mouth odour that resolves within weeks; others notice no issue at all. Both medications require a UK prescription following clinical assessment by your GP or a licensed prescriber. If you experience persistent bad breath on either medication, inform your prescriber — they can assess whether it's related to the injection, your diet, hydration, or underlying oral health, and adjust your dose or treatment plan accordingly.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can I prevent bad breath when taking Mounjaro or Wegovy?
Yes. Stay well hydrated, maintain good oral hygiene (brush twice daily, floss, use mouthwash), eat slowly, avoid foods that worsen odour (garlic, onions, coffee), and chew sugar-free gum or mints. Discuss persistent issues with your prescriber — they may adjust your dose or suggest dietary changes.
Is bad breath more common with Mounjaro or Wegovy?
Clinical trials don't directly compare halitosis rates. Both medications slow digestion, which can contribute to bad breath. Individual variation is high — some people experience it, others don't. Your prescriber can help determine which medication suits you best following a clinical assessment.
How long does bad breath last on these injections?
Typically 2–4 weeks as your body adjusts. If it persists beyond this, inform your GP or prescriber. It may resolve if your dose is adjusted, your diet is optimised, or if the medication is changed.
Does Mounjaro's dual mechanism (GIP+GLP-1) cause worse bad breath than Wegovy's single GLP-1 mechanism?
Not necessarily. Both slow gastric emptying, the main factor causing bad breath. Mounjaro's additional GIP pathway hasn't been shown to worsen this particular side effect. Individual response varies more than the medication type.
Should I stop Mounjaro or Wegovy if I get bad breath?
No — contact your GP or prescriber first. Bad breath is usually manageable and often temporary. They may suggest lifestyle adjustments, hydration changes, or dose optimisation before considering switching medication. Never stop prescription medication without medical guidance.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.